|4Jan 27, 8:07 PM ET

CymaBay Therapeutics, Inc. 4

4 · CymaBay Therapeutics, Inc. · Filed Jan 27, 2015

Insider Transaction Report

Form 4
Period: 2015-01-07
Boudes Pol F
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2015-01-07+75,00075,000 total
    Exercise: $10.00Exp: 2025-01-07Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]The option vests with respect to one-quarter of the underlying shares upon the first anniversary of the grant date, and then with respect to the remaining shares monthly thereafter over the next three years.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -